The price of DLB is predicted to go up 0%, based on the high correlation periods with ABVC. The similarity of these two price pattern on the periods is 97.33%.

DLB

ABVC

Up: 0%Similarity: 97.33%

DLB Revenue Forecast

DLB EPS Forecast

DLB FAQs

What is bull’s view on DLB?

Barrington and Rosenblatt analysts maintain a bullish view on Dolby Laboratories (DLB) with a price target of $100, reflecting a 24% upside from the current price of $80.63. This optimism is driven by strong Q1 2025 earnings, with adjusted EPS of $1.14 surpassing consensus estimates. However, insider selling activity may temper investor confidence despite the positive analyst sentiment.

What is bear's view on DLB?

DLB stock currently trades at $80.63, and bearish sentiment arises from insider selling, including a significant sale by EVP Mark Andrew Sherman, which indicates potential lack of confidence in the stock's near-term performance. Additionally, despite strong Q1 2025 results, the stock's valuation may appear stretched, with limited upside to its recent high of $85.30. Bears may also argue that the 24% upside to the $100 price target is overly optimistic given the negative insider sentiment and market uncertainties.